Trial Profile
A retrospective trial evaluating the efficacy of Irinotecan [CPT-11 charged microbeads] in uveal melanoma patients with liver metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Uveal melanoma
- Focus Adverse reactions; Therapeutic Use
- 09 Feb 2016 New trial record